$LINDEINDIA

Linde India operates in the Other Chemical Products sector, where it holds the position of the second-largest company by market capitalisation. The broader chemicals sector in India has faced challenges from global overcapacity, fluctuating raw material prices, and varying demand patterns across end-user industries. The company's modest 3.79% year-on-year revenue growth in Q4 FY26 reflects these challenging market conditions. Over a five-year horizon, Linde India has delivered sales growth of 11.26% annually, which is respectable but not exceptional for a company commanding premium valuations. More impressively, EBIT has grown at 29.22% annually over the same period, though the recent quarterly performance suggests this growth trajectory may be moderating. The company's market capitalisation of ₹58,841 crores positions it as a mid-cap player in the Indian equity markets. The industrial gases segment, Linde India's core business, typically serves diverse industries including steel, chemicals, healthcare, and food processing. Demand patterns are closely linked to industrial production and economic activity. The sharp sequential revenue decline in Q4 FY26 may reflect seasonal factors, project timing issues, or broader industrial slowdown concerns that warrant close monitoring in coming quarters.